Cholesterosis of the gallblader and clinical and diagnostical characteristics of patients with different body weight


DOI: https://dx.doi.org/10.18565/therapy.2023.7.46-54

Girfanova L.G., Khlynova O.V.

1) Medical center «Office of Dr. Girfanova», Perm; 2) Academician E.A. Wagner Perm State Medical University of the Ministry of Healthcare of Russia
Abstract. Gallbladder cholesterosis (GBC) has been studied more often in overweight and obese patients, however, this disease is often found in people with normal weight too.
The aim: to study the clinical and metabolic peculiaritiess of GBC patients with normal body mass and overweight.
Material and methods. We examined 100 patients with GBC: 54 with normal (subgroup 1 – 23 male and 31 female patients, median age 39 years) and 46 – with overweight (subgroup 2 – 24 male and 22 female patients, median age 46 years). All participants underwent a general clinical examination, ultrasound of the abdominal organs and brachiocephalic arteries (BCA), diagnostics of H. pylori presence, assessment of the gallbladder contractile function. Patients with dyspepsia underwent fibrogastroscopy.
Results. In patients with GBC, the clinical picture was characterized by syndromes of intestinal dyspepsia (33–47%), biliary dysfunction (30–33%), abdominal pain syndrome and gastric dyspepsia (37–43%). Both subgroups were found to be highly infected with H. pylori (68–76%). In subgroup 1, a direct correlation was fixed between H. pylori infection and GBC development, the level of H. pylori antibodies and the value of the atherogenic index. In subgroup 2, atherogenic dyslipidemia (58,6%), atherosclerotic changes in BCA (28,3%) were detected. An increase in ultrasensitive CRP in 50% of patients in subgroup 2 correlated with the thickness of the intima-media complex (IMC) and LDL levels. In subgroup 1 prevailed polyposis (87%), in subgroup 2 – polyposis and reticular- polyposis (91,4%) forms of GBC, which indicates at the diffuse lesion of gallbladder wall. Contractile function of this organ was reduced in both subgroups.
Conclusion. In patients with normal body weight, H. pylori is probably playing the role in the pathogenesis of the polyposis form of GBC in the absence of systemic metabolic changes. In overweight patients, GBC is associated with impaired lipid metabolism, an increase in the thickness of IMT in the carotid arteries, atherogenic dyslipidemia, and a high level of subclinical inflammation.
H. pylori is probably one of the triggers, but not the leading factor in the development of GBC in this subgroup.

Literature


1. Буторова Л.И. Холестероз желчного пузыря: патогенез, клиника, диагностика, принципы консервативной терапии. Пособие для врачей. М.: Форте принт. 2012; 36 с. [Butorova L.I. Cholesterosis of the gallbladder: Pathogenesis, clinic, diagnosis, principles of conservative therapy. A manual for doctors. Moscow: Forte print. 2012; 36 pp. (In Russ.)]. ISBN: 978-5-905757-04-4. EDN: QMCENH.


2. Ильченко А.А. Болезни желчного пузыря и желчных путей. Руководство для врачей. М.: ООО «Издательство «Медицинское информационное агентство»». 2011; 880 с. [Ilchenko A.A. Diseases of the gallbladder and biliary tract. Guide for doctors. Moscow: Medical News Agency Publishing House LLC. 2011: 880 pp. (In Russ.)]. ISBN: 978-5-9986-0050-0.


3. Патент РФ на изобретение № RU 2276967C2/ 26.07.2004. Лазебник Л.Б., Ильченко А.А., Орлова Ю.Н., Хомерики С.Г., Сильвестрова С.Ю., Дроздов В.Н., Лычкова А.Э. Способ диагностики холестероза желчного пузыря. [Patent RU for invention No. RU 2276967C2/ 26.07.2004. Lazebnik L.B., Ilchenko A.A., Orlova Yu.N., Khomeriki S.C., Silvestrova S.Yu., Drozdov V.N., Lychkova A.E. Method for diagnosis of gallbladder cholesterosis (In Russ.)].


4. Горбатюк И.Б. Особенности динамической ультрасонографии при холестерозе желчного пузыря в зависимости от индекса массы тела. Colloqium-Journal. 2019; (18–1): 63–66. [Gorbatyuk I.B. Features of dynamic ultrasonography for gallbladder cholesterosis depending on body weight. Colloqium-Journal. 2019; (18–1): 63–66 (In Russ.)]. EDN: BGVBYO.


5. Kawaguchi M. Saito T. Ohno H. et al. Bacteria closely resembling H. pylori detected immunogistologically and genetically in resected gallbladder mucosa. J Gastroenterol. 1996; 31(2): 294–98. https://dx.doi.org/10.1007/BF02389534.


6. Cen L., Pan J., Zhou B. et al. Helicobacter pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta–analysis. Helicobacter. 2018; 23(1). https://dx.doi.org/10.1111/hel.12457.


7. Савельев В.С., Петухов В.А., Каралкин А.В., Фомин Д.К. Внепеченочные билиарные дисфункции при липидном дистресс-синдроме: этиопатогенез, диагностика и принципы лечения. РМЖ. 2002; 10(2): 62. [Saveliev V.S., Petukhov V.A., Karalkin A.V., Fomin D.K. Extragepatic biliary dysfunction in lipid distress-syndrome: Etiopathogenesis, diagnosis and principles of treatment. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2002; 10(2): 62 (In Russ.)].


8. Sumida Y., Kanemasa K., Imai S. et al. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J Gastroenterol. 2015; 50(9): 996–1004. https://dx.doi.org/10.1007/s00535-015-1039.


9. Манякина О.М, Аккуратова-Максимова И.С., Пухова Т.Г, Шитова А.С. Роль генетической структуры Helicobacter pylori в формировании хронического воспалительного процесса в слизистой оболочке желудка. Пермский медицинский журнал. 2021; 38(1): 87–99. [Manyakina O.M., Akkuratova-Maksimova I.S., Pukhova T.G., Shitova A.S. The role of the genetic structure of Helicobacter pylori in the formation of a chronic inflammatory process in the gastric mucosa. Permskiy meditsinskiy zhurnal = Perm Medical Journal. 2021; 38(1): 87–99 (In Russ.)]. https://dx.doi.org/10.17816/pmj38187-99. EDN: XXQHBY.


About the Autors


Liliya G. Girfanova, gastroenterologist, doctor of ultrasound diagnostics at the Medical center «Office of Dr. Girfanova». Address: 614006, Perm, 10 Lenina Str.
E-mail: cicuta@list.ru
ORCID: https://orcid.org/0000-0001-7373-0416
Olga V. Khlynova, MD, professor, corresponding member of RAS, head of the Department of hospital therapy and cardiology, Academician E.A. Wagner Perm State Medical University of the Ministry of Healthcare of Russia. Address: 614000, Perm, 26 Petropavlovskaya Str.
E-mail: olgakhlynova@mail.ru
ORCID: https://orcid.org/0000-0003-4860-0112


Similar Articles


Бионика Медиа